Earnings Feed
Start Free
Home/Filings/4/0001567619-21-021722
4//SEC Filing

Butler Thomas Andrew 4

Accession 0001567619-21-021722

CIK 0001840439other
View on SEC.govCompany Profile

Filed

Dec 6, 7:00 PM ET

Accepted

Dec 7, 5:27 PM ET

Size

9.4 KB

Accession

0001567619-21-021722

Insider Transaction Report

Form 4
Period: 2021-12-04
Biomea Fusion, Inc.BMEA
Butler Thomas Andrew
DirectorCEO10% Owner
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-12-04+305,400→ 305,400 total
    Exercise: $9.80Exp: 2031-12-03→ Common Stock (305,400 underlying)
Holdings

  • Common Stock

    (indirect: See Footnote)
    252,320

  • Common Stock

    310,736

  • Common Stock

    (indirect: See Footnote)
    228,470

  • Common Stock

    (indirect: See Footnote)
    4,365,342
Footnotes (4)
  • [F1]The shares are held directly by Point Sur Investors Fund I, LP ("Point Sur LP"). The General Partner of Point Sur LP is Point Sur Investors LLC. Rainer M Erdtmann and Thomas Butler are the managing members of Point Sur Investors, LLC and as such have voting and dispositive power over the securities held by Point Sur LP. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
  • [F2]The shares are held directly by Point Sur Investors, LLC. Rainer M Erdtmann and Thomas Butler are the managing members of Point Sur Investors, LLC and as such have voting and dispositive power over the securities held by Point Sur Investors, LLC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
  • [F3]The shares are held directly by Biomea Health, LLC. Rainer M. Erdtmann and Thomas Butler each hold 50% ownership of Biomea Health LLC. Rainer M Erdtmann and Thomas Butler are managing members of Biomea Health, LLC and as such have voting and dispositive power over the securities held by Biomea Health LLC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
  • [F4]The option shall vest and become exercisable in quarterly installments over four years, subject to the Reporting Person's continued service to the Issuer through each vesting date.

Documents

1 file

Issuer

Biomea Fusion, Inc.

CIK 0001840439

→
Entity typeother

Related Parties

1
  • filerCIK 0001857171

Filing Metadata

Form type
4
Filed
Dec 6, 7:00 PM ET
Accepted
Dec 7, 5:27 PM ET
Size
9.4 KB
View on SEC.gov